Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised Egetis Therapeutics in connection with a directed share issue
Mandate

Vinge has advised Egetis Therapeutics in connection with a directed share issue

January 27, 2023 Capital Markets and Public M&A Life Sciences & Health

Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), an innovative and integrated pharmaceutical company focusing on projects in late-stage development for commercialization for treatments of serious diseases with significant unmet medical needs in the orphan drug segment, listed on Nasdaq Stockholm, in connection with a directed share issue whereby the company raised proceeds of SEK 210 million before issue costs.

The share issue was directed to a number of selected Swedish and international institutional investors on the basis of an accelerated bookbuilding process.

Vinge’s team consisted of Dain Hård Nevonen, Amanda Knutsson and Lorin Arabi.

Related

Vinge represents Cinven in connection with the acquisition of Ongoing Warehouse

 Vinge has represented the international private equity firm Cinven in connection with its acquisition of Ongoing Warehouse.
May 06, 2026

Vinge advises Turbine Capital and Almi Invest GreenTech on an investment in Enairon

 Turbine Capital is leading a SEK 45 million investment round in the Swedish company Enairon, together with Almi Invest GreenTech, the European Innovation Council Fund, and existing investors. Enairon is a Swedish industrial company based in Halmstad, which develops a patented compressed air technology based on water and gravity, aimed at industrial companies globally where compressed air is a central part of production.
May 05, 2026

Vinge has represented Anaqua, a portfolio company of Nordic Capital, in connection with the acquisition of Patrix

 Vinge has represented Anaqua, Inc., a portfolio company of Nordic Capital, in connection with the acquisition of Patrix Aktiebolag, provider of IP management software and services. The acquisition is a strategic addition to Anaqua's platform, further expanding its European presence.
April 30, 2026